Supplemental material
Open access
11,716
Views
31
CrossRef citations to date
0
Altmetric
Report
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
Janet SimALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
https://orcid.org/0000-0002-6438-1995
Jonathan T. SockoloskyALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
https://orcid.org/0000-0002-5441-1409
Emma SangalangALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
https://orcid.org/0000-0002-6222-6588
Shelley IzquierdoLigand Pharmaceuticals, Inc, Emeryville, CA, USA
, Darlene PedersenLigand Pharmaceuticals, Inc, Emeryville, CA, USA
, William HarrimanLigand Pharmaceuticals, Inc, Emeryville, CA, USA
, Ardian S. WibowoHelix Biostructures, Columbus, IN, USA
https://orcid.org/0000-0002-0955-8903
Josh CarterHelix Biostructures, Columbus, IN, USA
https://orcid.org/0000-0001-7322-349X
Anup MadanCovance Genomics Laboratory, Redmond, WA, USA
https://orcid.org/0000-0002-0967-7574
Laura DoyleALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
https://orcid.org/0000-0003-1241-7017
Ons HarrabiALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
, Steven E. KauderALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
https://orcid.org/0000-0003-4853-6544
Amy ChenALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
, Tracy C. KuoALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
https://orcid.org/0000-0001-6297-8694
Hong WanALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USA
https://orcid.org/0000-0003-2537-8950
Jaume PonsALX Oncology, Departments of Protein Sciences and Translational Biology, Burlingame, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-0831-419X
Pages 1036-1052
|
Received 01 Feb 2019, Accepted 17 May 2019, Published online: 01 Jul 2019
Related Research Data
A rapid approximation to the solvent accessible surface areas of atoms
Source:
Elsevier BV
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Source:
American Association for the Advancement of Science (AAAS)
Antibodies targeting closely adjacent or minimally overlapping epitopes can displace one another
Source:
Public Library of Science (PLoS)
Therapeutic activity of an interleukin-4/interleukin-13 dual antagonist on oxazolone-induced colitis in mice
Source:
Wiley
An integrated map of structural variation in 2,504 human genomes
Source:
eScholarship, University of California
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
Source:
Springer Science and Business Media LLC
In vitro characterization of five humanized OKT3 effector function variant antibodies.
Source:
Elsevier BV
Positive Regulation of Phagocytosis by SIRPβ and Its Signaling Mechanism in Macrophages
Source:
Elsevier BV
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile.
Source:
Public Library of Science (PLoS)
Environment and exposure to solvent of protein atoms. Lysozyme and insulin.
Source:
Elsevier BV
Localized CD47 blockade enhances immunotherapy for murine melanoma
Source:
Proceedings of the National Academy of Sciences
:{unav)
Source:
Wiley
:{unav)
Source:
Wiley
High-efficiency antibody discovery achieved with multiplexed microscopy.
Source:
Oxford University Press (OUP)
Binding of blood proteins to carbon nanotubes reduces cytotoxicity
Source:
Proceedings of the National Academy of Sciences
“Velcro” Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein α (SIRPα) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.